Denali Therapeutics Inc header image

Denali Therapeutics Inc

DNLI

Equity

ISIN null / Valor 39149539

NASDAQ (2026-06-26)

USD 25.57+3.40%

Denali Therapeutics Inc
UMushroom community rating:

3.00 1 votes No rating yet

NegativeNeutralPositive

About company

Denali Therapeutics Inc is a biotechnology company focused on developing therapies for neurodegenerative and lysosomal storage diseases. Leveraging their expertise in the biology of these conditions, the company's core portfolio includes programs in various stages of clinical and preclinical development aimed at addressing the underlying causes of these diseases. With a commitment to rigorous therapeutic discovery and development, Denali is dedicated to advancing molecular therapeutics that have the potential to significantly improve the lives of patients facing these challenging medical conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

76.5%1Y

-10.8%3Y

-65.8%5Y

Performance

56.5%1Y

62.2%3Y

61.9%5Y

Volatility

4058 M

Market cap (USD)

6,526,874

Daily traded volume (Shares)

20.49 / 19.93

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.00

1 votes

Performance:

3.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

John Noyb

Switzerland, 25 Jun 2025

Q

EQUITIES OF THE SAME SECTOR

Spire Healthcare Group PLC

Spire Healthcare Group PLC Valor: 24881418

Annual Return

-50%0%+50%

Risk level

110

-0.46%GBP 2.17

medmix Ltd

medmix Ltd Valor: 112967710

Annual Return

-50%0%+50%

Risk level

110

0.38%CHF 7.90

NATCO Pharma Limited

NATCO Pharma Limited Valor: 30461955

Annual Return

-50%0%+50%

Risk level

110

1.06%INR 903.45

IQVIA Holdings Inc

IQVIA Holdings Inc Valor: 39103858

Annual Return

-50%0%+50%

Risk level

110

2.53%USD 191.14

Vijaya Diagnostic Centre Ltd.

Vijaya Diagnostic Centre Ltd. Valor: 113420241

Annual Return

-50%0%+50%

Risk level

110

4.08%INR 1,366.85

Anthem Biosciences Limited

Anthem Biosciences Limited Valor: 146882011

Annual Return

-50%0%+50%

Risk level

110

-1.19%INR 761.15

Cencora Inc

Cencora Inc Valor: 1212868

Annual Return

-50%0%+50%

Risk level

110

-0.29%USD 286.13

Resmed Inc

Resmed Inc Valor: 321632

Annual Return

-50%0%+50%

Risk level

110

0.85%USD 200.29

International Flavors & Fragrances Inc

International Flavors & Fragrances Inc Valor: 941876

Annual Return

-50%0%+50%

Risk level

110

1.69%USD 76.35

Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc Valor: 1262932

Annual Return

-50%0%+50%

Risk level

110

2.35%USD 93.10

SIX

FactSet

Clearbit

Logos provided by Clearbit